Molecular Templates Faces Nasdaq Delisting After Multiple Compliance Failures - Stock Titan
2024-12-19 • Google News
Molecular Templates Inc (MTEM)
US$ 00%
Price Chart
Key Statistics
Market Cap
$ 658
P/E Ratio
0.00
Revenue (TTM)
$ 25.47M
Volume
0
52W High
$ 1.48
52W Low
$ 0.00
Dividend Yield
0.00%
Beta
1.53
Technicals
50-Day MA
0.0002
200-Day MA
0.4183
52 Week High
1.48
52 Week Low
0.0001
About MTEM
Molecular Templates, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of biologic therapeutics for the treatment of cancer and other serious diseases in the U.
Employees
62
Headquarters
Austin, TX
CEO
Dr. Eric E. Poma Ph.D.